Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma
Authors
Keywords
Exosome, GRP78, Sorafenib, Growth, Metastasis, Hepatocellular carcinoma
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-20
DOI
10.1186/s12951-018-0429-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo
- (2018) Chang Yu et al. BIOMATERIALS
- MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity
- (2018) Shipin Zhang et al. BIOMATERIALS
- GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway
- (2018) Chenglin Luo et al. EXPERIMENTAL CELL RESEARCH
- Overexpression of endoplasmic reticulum stress-related proteins, XBP1s and GRP78, predicts poor prognosis in pulmonary adenocarcinoma
- (2018) Dohee Kwon et al. LUNG CANCER
- Exosome Therapy for Stroke
- (2018) Jieli Chen et al. STROKE
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
- (2018) Jing Ren et al. Theranostics
- Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes
- (2018) Shahrzad Nojehdehi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration
- (2017) Xiaofei Cheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth
- (2017) Daniele Bellavia et al. Theranostics
- Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance
- (2017) Miao Yu et al. Artificial Cells Nanomedicine and Biotechnology
- Inhibition of acquired-resistance hepatocellular carcinoma cell growth by combining sorafenib with phosphoinositide 3-kinase and rat sarcoma inhibitor
- (2016) Chang-Hao Wu et al. JOURNAL OF SURGICAL RESEARCH
- Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma
- (2015) E. A. Kuczynski et al. CANCER RESEARCH
- Exosomes as drug delivery vehicles for Parkinson's disease therapy
- (2015) Matthew J. Haney et al. JOURNAL OF CONTROLLED RELEASE
- Hepatocellular carcinoma surveillance with miRNAs
- (2015) Alejandro Forner LANCET ONCOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
- (2015) Alice Conigliaro et al. Molecular Cancer
- Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells
- (2014) Gan Lin et al. BIOMATERIALS
- Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
- (2014) M. Ono et al. Science Signaling
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Additive antileukemia effects by GFI1B- and BCR–ABL-specific siRNA in advanced phase chronic myeloid leukemic cells
- (2013) M Koldehoff et al. CANCER GENE THERAPY
- Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications
- (2013) Chiara Corrado et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles
- (2013) Sander A.A. Kooijmans et al. JOURNAL OF CONTROLLED RELEASE
- Exosomes for targeted siRNA delivery across biological barriers
- (2012) Samir EL Andaloussi et al. ADVANCED DRUG DELIVERY REVIEWS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line
- (2010) Huan Meng et al. ACS Nano
- Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma
- (2009) Jeng-Fong Chiou et al. ANNALS OF SURGICAL ONCOLOGY
- Exosomes – vesicular carriers for intercellular communication
- (2009) Mikael Simons et al. CURRENT OPINION IN CELL BIOLOGY
- Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas
- (2008) Hua-chuan Zheng et al. HUMAN PATHOLOGY
- Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis
- (2008) B H Y Yeung et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started